Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye

Annual Review of Nutrition

Volumn 23, Issue , 2003, Pages 171-201

  Krinsky, Norman I ^a   Landrum, John T ^b   Bone, Richard A ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Age related macular degeneration; Antioxidant; Carotenoid action; Color filter; Macula

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID; LIPOFUSCIN; REACTIVE OXYGEN METABOLITE; SELENIUM; XANTHOPHYLL; ZEAXANTHIN;

ANTIOXIDANT ACTIVITY; CATARACT; CHOROIDEREMIA; COLOR; DIET SUPPLEMENTATION; DIET THERAPY; DRUG MECHANISM; EYE PROTECTION; FLUORESCENCE; HUMAN; ISOMERISM; KALE; LIGHT ABSORPTION; LIGHT DAMAGE; MYOPIA; NONHUMAN; NUTRIENT; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PHOTOMETRY; PHOTORECEPTOR CELL; PHOTOSENSITIZATION; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REFLECTOMETRY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SPINACH; VEGETABLE; VISUAL DISORDER;

AGE FACTORS; AGING; ANTIOXIDANTS; BETA CAROTENE; CATARACT; HUMANS; LUTEIN; MACULA LUTEA; MACULAR DEGENERATION; RETINA; RETINAL PIGMENTS; RISK FACTORS; XANTHOPHYLLS;

BRASSICA OLERACEA VAR. ACEPHALA; PRIMATES; SPINACIA OLERACEA;

EID: 0042866149     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.23.011702.073307     Document Type: Review

References (165)

1. Abadi RV, Cox MJ. 1992. The distribution of macular pigment in human albinos. Invest. Ophthalmol. Vis. Sci. 33:494-97
2. Age-Related Eye Disease Study Research Group. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch. Ophthalmol, 119:1439-52
3. Age-Related Eye Disease Study Research Group. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119:1417-36
4. Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, et al. 2001. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest. Ophthalmol. Vis. Sci. 42:1873-81
5. Andrewes AG, Borch G, Liaaen-Jensen S. 1974. Carotenoids of higher plants. 7. On the absolute configuration of lutein. Acta Chem. Scand. B 28:139-40
6. Anonymous. 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC:Natl. Acad. Press. 506 pp.
7. Beatty S, Boulton M, Henson D, Koh HH, Murray IJ. 1999. Macular pigment and age related macular degeneration. Br. J. Ophthalmol. 83:867-77
8. Beatty S, Koh H, Phil M, Henson D, Boulton M. 2000. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45:115-34
9. Beatty S, Murray IJ, Henson DB, Carden D, Koh H-H, Boulton ME. 2001. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest. Ophthalmol. Vis. Sci. 42:439-46
10. Berendschot TTJM, Goldbohm RA, Klöpping WAA, van de Kraats J, van Norel J, van Norren D. 2000. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest. Ophthalmol. Vis. Sci. 41:3322-26
11. Bernstein PS, Balashov NA, Tsong ED, Rando RR. 1997. Retinal tubulin binds macular carotenoids. Invest. Ophthalmol. Vis. Sci. 38:167-75
12. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao D-Y, Katz NB. 2001. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp. Eye Res. 72:215-23
13. Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W. 1998. Raman detection of macular carotenoid pigments in intact human retina. Invest. Ophthalmol. Vis. Sci. 39:2003-11
14. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. 2002. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109:1780-87
15. Block G, Woods M, Potosky A, Clifford C. 1990. Validation of a self administered diet history questionnaire: multiple diet records. J. Clin. Epidemiol. 43:1327-35
16. Bone RA, Landrum JT. 1983. Dichroism of lutein: a possible basis for Haidinger's brushes. Appl. Opt. 22:775-76
17. Bone RA, Landrum JT. 1984. Macular pigment in Henle fiber membranes: a model for Haidinger's brushes. Vision Res. 24:103-8
18. Bone RA, Landrum JT, Cains A. 1992. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res. 32:105-10
19. Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM. 2000. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp. Eye Res. 71:239-45
20. Bone RA, Landrum JT, Fernandez L, Tarsis SL. 1988. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest. Ophthalmol. Vis. Sci. 29:843-49
21. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilbum MD, et al. 1997. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp. Eye Res. 64:211-18
22. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. 1993. Stereochemistry of the Human Macular Carotenoids. Invest. Ophthalmol. Vis. Sci. 34:2033-40
23. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. 2001. Macular pigment in donor eyes with and without AMD: a case-control study. Invest. Ophthalmol. Vis. Sci. 42:235-40
24. Bone RA, Landrum JT, Tarsis SL. 1985. Preliminary identification of the human macular pigment. Vision Res. 25:1531-35
25. Bour LJ, Koo L, Delori FC, Apkarian P, Fulton AB. 2002. Fundus photography for measurement of macular pigment density distribution in children. Invest. Ophthalmol. Vis. Sci. 43:1450-55
26. Brindley GS, Willmer EN. 1952. The reflexion of light from the macular and peripheral fundus oculi in man. J. Physiol. 116:350-56
27. Britton G. 1995. UV/visible spectroscopy. In Carotenoids, ed. G Britton, S Liaaen-Jensen, H Pfander, pp. 13-62. Basel, Switzerland: Birkhäuser
28. Broekmans WMR, Berendschot TTJM, Klöpping-Ketelaars IAA, de Vries AJ, Goldbohm RA, et al. 2002. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am. J. Clin. Nutr. 76:595-603
29. Brown L, Rimm EB, Seddon JM, Giovannucci EL, Chasan-Taber L, et al. 1999. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am. J. Clin. Nutr. 70:517-24
30. Buchecker R, Eugster CH, Weber A. 1978. Absolute konfiguration von α-doradexanthin and von frishiellaxanthin, einem neuen carotinoid aus Fritschiella tuberosa Iyeng. Helv. Chim. Acta 61:1962-68
31. Buchecker R, Noack K. 1995. Circular dichroism. In Carotenoids, ed. G Britton, S Liaaen-Jensen, H Pfander, pp. 63-116. Basel, Switzerland: Birkhäuser
32. Burton GW. 1989. Antioxidant action of carotenoids. J. Nutr. 119:109-11
33. Burton GW, Ingold KU. 1984. β-Carotene: an unusual type of lipid antioxidant. Science 224:569-73
34. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, et al. 1999. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am. J. Clin. Nutr. 70:509-16
35. Chylack LT Jr., Brown NP, Bron A, Hurst M, Köpcke W, et al. 2002. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol. 9:49-80
36. Ciulla TA, Curran-Celentano J, Cooper DA, Hammond BR Jr., Danis RP, et al. 2001. Macular pigment optical density in a midwestern sample. Ophthalmology 108:730-37
37. Ciulla TA, Harris A, Chung HS, Danis RP, Kagemann L, et al. 1999. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Am. J. Ophthalmol. 128:75-80
38. Coren S, Girgus JS. 1972. Density of human lens pigmentation: in vivo measures over an extended age range. Vision Res. 12:343-46
39. Craft NE. 1992. Carotenoid reversed-phase high-performance liquid chromatography methods: reference compendium. Methods Enzymol. 213:185-205
40. Curran-Celentano J, Hammond BR Jr., Ciulla TA, Cooper DA, Pratt LM, Danis RB. 2001. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am. J. Clin. Nutr. 74:796-802
41. Dagnelie G, Zorge IS, McDonald TM. 2000. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 71:147-64
42. Delori FC, Goger DG, Dorey CK. 2001. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest. Ophthalmol. Vis. Sci. 42:1855-66
43. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. 2001. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J. Opt. Soc. Am. 18:1212-30
44. Delori FC, Pflibsen KP, 1989. Spectral reflectance of the human ocular fundus. Applied Optics 28:1061-77
45. DeVries HL, Spoor A, Jielof R. 1953. Properties of the eye with respect to polarized light. Physica 19:419-32
46. Dorey CK, Staurenghi G, Delori F, Sarks S, Sarks J. 1993. Lipofuscin fluorescence in donor eyes with AMD. Invest. Ophthalmol. Vis. Sci. 34:1161
47. Duncan JL, Aleman TS, Gardner LM, De Castro E, Marks DA, et al. 2002. Macular pigment and lutein supplementation in choroideremia. Exp. Eye Res. 74:371-81
48. Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, et al. 2001. Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation 103:2922-27
49. Eagle RC Jr. 1984. Mechanisms of maculopathy. Ophthalmology 91:613-25
50. Eliel EL. 1962. Stereochemistry of Carbon Compounds. New York: McGraw-Hill
51. Erdman JW Jr., Bierer TL, Gugger ET. 1993. Absorption and transport of carotenoids. In Carotenoids in Human Health, ed. LM Canfield, NI Krinsky, JA Olson, pp. 76-86. New York: NY Acad. Sci.
52. Eye Disease Case-Control Study Group. 1992. Risk factors for neovascular age-related macular degeneration. Arch. Ophthalmol. 110:1701-8
53. Eye Disease Case-Control Study Group. 1993. Antioxidant status and neovascular age-related macular degeneration. Arch. Ophthalmol. 111:104-9
54. Foote CS, Chang YC, Denny RW. 1970. Chemistry of singlet oxygen. X. Carotenoid quenching parallels biological protection. J. Am. Chem. Soc. 92:5216-18
55. Gale CR, Hall NF, Phillips DI, Martyn CN. 2001. Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 108:1992-98
56. Gao G, Wei CC, Jeevarajan AS, Kispert LD. 1996. Geometrical isomerization of carotenoids mediated by cation radical/dication formation. J. Phys. Chem. 100:5362-66
57. Gellermann W, Ermakov IV, McClane RW, Bernstein PS. 2002. Raman imaging of human macular pigments. Optics Lett. 27:833-35
58. Goodman GE, Valanis B, Meyskens FL Jr., Williams JH Jr., Metch BJ, et al. 1998. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial. Cancer Epidemiol. Biomarkers Prev. 7:405-12
59. Goodwin TW. 1980. The Biochemistry of the Carotenoids. London: Chapman & Hall. 377 pp.
60. Goodwin TW. 1984. The Biochemistry of the Carotenoids. London: Chapman & Hall. 224 pp.
61. Grant JL, Kramer VJ, Ding R, Kispert LD. 1988. Carotenoid cation radicals: electrochemical, optical, and EPR study. J. Am. Chem. Soc. 110:2151-57
62. Gruszecki WI, Sujak A, Strzalka K, Radunz A, Schmid GH. 1999. Organisation of xanthophyll-lipid membranes studied by means of specific pigment antisera, spectrophotometry and monomolecular layer technique lutein versus zeaxanthin. Z. Naturforsch. [C] 54:517-25
63. Haegerstrom-Portnoy G. 1988. Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment? J. Opt. Soc. Am. A 5:2140-44
64. Halliwell B, Gutteridge JM. 1995. The definition and measurement of antioxidants in biological systems [letter; comment]. Free Radic. Biol. Med. 18:125-26
65. Ham WT. 1983. Ocular hazards of light sources: review of current knowledge. J. Occup. Med. 25:101-3
66. Ham WTJ, Mueller HA, Ruffolo JJ, Millen JE, Cleary SF, et al. 1984. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr. Eye Res. 3:165-74
67. Hammond BR Jr., Curran-Celentano J, Judd S, Fuld K, Krinsky NI, et al. 1996. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res. 36:2001-12
68. Hammond BR Jr., Johnson EJ, Russell RM, Krinsky NI, Yeum K-J, et al. 1997. Dietary modification of human macular pigment density. Invest. Ophthalmol. Vis. Sci. 38:1795-801
69. Hammond BR Jr., Wooten BR, Snodderly DM. 1997. Individual variations in the spatial profile of human macular pigment. J. Opt. Soc. Am. A 14:1187-96
70. Hammond BR Jr., Wooten BR, Snodderly DM. 1998. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest. Ophthalmol. Vis. Sci. 39:397-406
71. Handelman GJ, Dratz EA, Reay CC, van Kuijk FJGM. 1988. Carotenoids in the human macula and whole retina. Invest. Ophthalmol. Vis. Sci. 29:850-55
72. Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JB. 1999. Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am. J. Clin. Nutr. 70:247-51
73. Hankinson SE, Stampfer MJ, Seddon JM, Colditz GA, Rosner BN, et al. 1992. Nutrient intake and cataract extraction in women: a prospective study. Brit. Med. J. 305:335-39
74. Harris A, Chung HS, Ciulla TA, Kagemann L. 1999. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog. Retin. Eye Res. 18:669-87
75. 2• radical. J. Am. Chem. Soc. 117:8322-26
76. Jacques PF. 1999. The potential preventive effects of vitamins for cataract and age-related macular degeneration. Int. J. Vitam. Nutr. Res. 69:198-205
77. Jaffe GJ, Wood IS. 1988. Retinal phototoxicity from the operating microscope: a protective effect by the fovea. Arch. Ophthalmol. 106:445-46
78. Johnson EJ, Hammond BR, Yeum K-J, Qin J, Wang XD, et al. 2000. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am. J. Clin. Nutr. 71:1555-62
79. Kaplan LA, Lau JM, Stein EA. 1990. Carotenoid composition, concentrations, and relationships in various human organs. Clin. Physiol. Biochem. 8:1-10
80. Khachik F, Beecher GR, Goli MB, Lusby WR, Smith JC Jr. 1992. Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal. Chem. 64:2111-22
81. Khachik F, Bernstein PS, Garland DL. 1997. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest. Ophthalmol. Vis. Sci. 38:1802-11
82. Khachik F, de Moura FF, Zhao D-Y, Aebischer C-P, Bernstein PS. 2002. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest. Ophthalmol. Vis. Sci. 43:3383-92
83. Khachik F, Spangler CJ, Smith JC Jr., Canfield LM, Steck A, Pfander H. 1997. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal. Chem. 69:1873-81
84. Khaled M, Hadjipetrou A, Kispert LD. 1990. Electrochemical and electron paramagnetic resonance studies of carotenoid cation radicals and dications: effect of deuteration. J. Phys. Chem. 94:5164-69
85. Kilbride PE, Alexander KR, Fishman M, Fishman GA. 1989. Human macular pigment assessed by imaging fundus reflectometry. Vision Res. 29:663-74
86. Kirschfeld K. 1982. Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc. R. Soc. Lond. B 216:71-85
87. Kohler BE. 1995. Electronic structure of carotenoids. In Carotenoids, ed. G Britton, S Liaaen-Jensen, H Pfander, pp. 1-12. Basel, Switzerland: Birkhäuser
88. Krinsky NI. 1989. Antioxidant functions of carotenoids. Free Radic. Biol. Med. 7:617-35
89. Krinsky NI. 2002. Possible biologic mechanisms for a protective role of xanthophylls. J. Nutr. 132:540S-42S
90. Landrum JT, Bone RA. 2001. Lutein, zeaxanthin, and the macular pigment. Arch. Biochem. Biophys. 385:28-40
91. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. 1997. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp. Eye Res. 65:57-62
92. Landrum JT, Bone RA, Kilbum MD. 1997. The macular pigment: a possible role in protection from age-related macular degeneration. Adv. Pharmacol. 38:537-56
93. Landrum JT, Bone RA, Moore LL, Gomez CM. 1999. Analysis of zeaxanthin distribution within individual human retinas. Methods Enzymol. 299:457-67
94. Le Marchand L, Hankin JH, Bach F, Kolonel LN, Wilkens LR, et al. 1995. An ecological study of diet and lung cancer in the South Pacific. Int. J. Cancer 63:18-23
95. Liaaen-Jensen S. 1971. Isolation, reactions. In Carotenoids, ed. O Isler, pp. 61-188. Basel/Stuttgart: Birkhäuser
96. Mangels AR, Holden JM, Beecher GR, Forman ME, Lanza E. 1993. Carotenoid content of fruits and vegetables: an evaluation of analytic data. J. Am. Diet. Assoc. 93:284-96
97. Maoka T, Arai A, Shimizu M, Matsuno T. 1986. The first isolation of enantiomeric and meso-zeaxanthin in nature. Comp. Biochem. Physiol. 83B:121-24
98. Mares-Perlman JA. 1999. Too soon for lutein supplements [editorial]. Am. J. Clin. Nutr. 70:431-32
99. Mares-Perlman JA, Klein R. 1999. Diet and age-related macular degeneration. In Nutritional and Environmental Influences on the Eye, ed. A Taylor, pp. 181-214. Boca Raton: CRC
100. Mares-Perlman JA, Klein R, Klein BEK, Greger JL, Brady WE, et al. 1996. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch. Ophthalmol. 114:991-97
101. Mares-Perlman JA, Millen AE, Ficek TL, Hankinson SE. 2002. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J. Nutr. 132:518S-24S
102. Martin H-D, Ruck C, Schmidt M, Sell S, Beutner S, et al. 1999. Chemistry of carotenoid oxidation and free radical reactions. Pure Appl. Chem. 71:2253-62
103. McLellan JS, Marcos S, Prieto PM, Burns SA. 2002. Imperfect optics may be the eye's defence against chromatic blur. Nature 417:174-76
104. Moeller SM, Jacques PF, Blumberg JB. 2000. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J. Am. Coll. Nutr. 19:522S-27S
105. Moreland JD, Robson AG, Soto-Leon N, Kulikowski JJ. 1998. Macular pigment and the colour-specificity of visual evoked potentials. Vision Res. 38:3241-45
106. Mortensen A, Skibsted LH, Truscott TG. 2001. The interaction of dietary carotenoids with radical species. Arch. Biochem. Biophys. 385:13-19
107. N'soukpoé-Kossi CN, Sielewiesiuk J, Leblanc RM, Bone RA, Landrum JT. 1988. Linear dichroism and orientational studies of carotenoid Langmuir-Blodgett films. Biochim. Biophys. Acta 940:255-65
108. Naylor EJ, Stanworth A. 1954. Retinal pigment and the Haidinger effect. J. Physiol. 124:543-52
109. Nebeling LC, Forman MR, Graubard BI, Snyder RA. 1997. Changes in carotenoid intake in the United States: the 1987 and 1992 National Health Interview Surveys. J. Am. Diet. Assoc. 97:991-96
110. Norren DV, Vos JJ. 1974. Spectral transmission of the human ocular media. Vision Res. 14:1237-44
111. Nussbaum JJ, Pruett RC, Delori FC. 1981. Historic perspectives. Macular yellow pigment. The first 200 years. Retina 1:296-310
112. Okulski W, Sujak A, Gruszecki WI. 2000. Dipalmitoylphosphatidylcholine membranes modified with zeaxanthin: numeric study of membrane organisation. Biochim. Biophys. Acta 1509:216-28
113. Palozza P, Krinsky NI. 1992. Antioxidant effects of carotenoids in vitro and in vivo: an overview. Methods Enzymol. 213:403-20
114. Pauleikhoff D, van Kuijk FJGM, Bird AC. 2001. Macular pigment and age-related macular degeneration. Ophthalmologe 98:511-19
115. Pease PL, Adams AJ. 1983. Macular pigment difference spectrum from sensitivity measures of a single cone mechanism. Am. J. Optom. Physiol. Opt. 60:667-72
116. Pryor WA, Stahl W, Rock CL. 2000. Beta carotene: from biochemistry to clinical trials. Nutr. Rev. 58:39-53
117. Rapp LM, Maple SS, Choi JH. 2000. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest. Ophthalmol. Vis. Sci. 41:1200-9
118. Rautalahti M, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Heinonen OP. 1997. Beta-carotene did not work: aftermath of the ATBC study. Cancer Lett. 114:235-36
119. Reading VM, Weale RA. 1974. Macular pigment and chromatic aberration. J. Opt. Soc. Amer. 64:231-34
120. Ritenbaugh C, Peng YM, Aickin M, Graver E, Branch M, Alberts DS. 1996. New carotenoid values for foods improve relationship of food frequency questionnaire intake estimates to plasma values. Cancer Epidemiol. Biomarkers Prev. 5:907-12
121. Ruddock KH. 1963. Evidence for macular pigmentation from colour matching data. Vision Res. 3:417-29
122. Ruttimann A, Schiedt K, Vecchi M. 1983. Separation of (3R,3′R)-, (3R,3′S)-, (3S,3′S)-zeaxanthin, (3R,3′R,6′R)-, (3R,3′S,6′S)-, and (3S,3′S,6′S)-lutein via the dicarbamates of (S)-(+)-a-[1-naphthyl]ethylisocyanate. J. High Res. Chrom. Commun. 6:612-16
123. Sample PA, Esterson FD, Weinreb RN, Boynton RM. 1988. The aging lens: in vivo assessment of light absorption in 84 human eyes. Invest. Ophthalmol. Vis. Sci. 29:1306-11
124. Sample PA, Quirante JS, Weinreb RN. 1991. Age-related changes in the human lens. Clinical assessment of age-related changes in the human lens. Acta Ophthalmol. (Copenh.) 69:310-14
125. Schalch W, Dayhew-Baker P, Barker FM II. 1999. The carotenoids of the human retina. In Nutritional and Environmental Influences on the Eye, ed. A Taylor, pp. 215-50. Boca Raton: CRC
126. Schiedt K. 1989. New aspects of carotenoid metabolism in animals. In Carotenoids: Chemistry and Biology, ed. NI Krinsky, MM Mathews-Roth, RF Taylor, pp. 247-68. New York/London: Plenum
127. Schiedt K, Bischof S, Glinz E. 1991. Recent progress on carotenoid metabolism in animals. Pure Appl. Chem. 63:89-100
128. Schiedt K, Leuenberger FJ, Vecchi M, Glinz E. 1985. Absorption, retention and metabolic transformations of carotenoids in rainbow trout, salmon and chicken. Pure Appl. Chem. 57:685-92
129. Schmitz HH, Poor CL, Gugger ET, Erdman JW Jr. 1993. Analysis of carotenoids in human and animal tissues. Methods Enzymol. 214:102-16
130. Schmitz HH, Poor CL, Wellman RB, Erdman JW Jr. 1991. Concentrations of selected carotenoids and vitamin A in human liver, kidney and lung tissue. J. Nutr. 121:1613-21
131. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, et al. 1994. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration (correction in JAMA 273:622, 1995). JAMA 272:1413-20
132. Shaban H, Richter C. 2002. A2E and blue light in the retina: the paradigm of age-related macular degeneration. Biol. Chem. 383:537-45
133. Smith W, Mitchell P, Rochester C. 1997. Serum beta carotene, alpha tocopherol, and age-related maculopathy: the Blue Mountains Eye Study. Am. J. Ophthalmol. 124:838-40
134. Smith W, Mitchell P, Webb K, Leeder SR. 1999. Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 106:761-67
135. Snodderly DM. 1995. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr. 62 (Suppl.):1448S-61S
136. Snodderly DM, Brown PK, Delori FC, Auran JD. 1984. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest. Ophthalmol. Vis. Sci. 25:660-73
137. Sommerburg O, Keunen JEE, Bird AC, van Kuijk FJGM. 1998. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Brit. J. Ophthalmol. 82:907-10
138. Sommerburg OG, Siems WG, Hurst JS, Lewis JW, Kliger DS, van Kuijk FJ. 1999. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr. Eye Res. 19:491-95
139. Straub O. 1987. Key to Carotenoids. Basel: Birkhäuser. 296 pp.
140. Surai PF, MacPherson A, Speake BK, Sparks NH. 2000. Designer egg evaluation in a controlled trial. Eur. J. Clin. Nutr. 54:298-305
141. Suter M, Remé C, Grimm C, Wenzel A, Jäättela M, et al. 2000. Age-related macular degeneration. The lipofuscin component of N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275:39625-30
142. Tabunoki H, Sugiyama H, Tanaka Y, Fujii H, Banno Y, et al. 2002. Isolation, characterization, and cDNA sequence of a carotenoid binding protein from the silk gland of Bombyx mori larvae. J. Biol. Chem. 277:32133-40
143. Teikari JM, Laatikainen L, Virtamo J, Haukka J, Rautalahti M, et al. 1998. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol. Scand. 76:224-29
144. Thomson LR, Toyoda Y, Langner A, Delori FC, Garnett KM, et al. 2002. Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest. Ophthalmol. Vis. Sci. 43:3538-49
145. Thomson LR, Toyoda Y, Langner A, Delori FC, Garnett KM, et al. 2002. Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail. Exp. Eye Res. 75:529-46
146. Truscott TG. 1996. β-Carotene and disease: a suggested pro-oxidant and antioxidant mechanism and speculations concerning its role in cigarette smoking. J. Photochem. Photobiol. B: Biol. 35:233-35
147. van de Kraats J, Berendschot TT, van Norren D. 1996. The pathways of light measured in funds reflectometry. Vision Res. 36:2229-47
148. Van Norren D, Tiemeijer LF. 1986. Spectral reflectance of the human eye. Vision Res. 26:313-20
149. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BEK, Brady WE, Palta M. 1998. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am. J. Epidemiol. 148:204-14
150. Wald G. 1945. Human vision and the spectrum. Science 101:653-58
151. Wald G. 1949. The photochemistry of vision. Doc. Ophthalmol. 3:94-137
152. Weale RA. 1953. Spectral sensitivity curves and the absorption of light by the ocular media. Brit. J. Ophthalmol. 37:148-57
153. Weedon BCL. 1971. Stereochemistry. In Carotenoids, ed. O Isler, pp. 267-323. Basel/Stuttgart: Birkhäuser
154. Werner JS, Donnelly SK, Kliegl R. 1987. Aging and human macular pigment density. Vision Res. 27:257-68
155. Woodall AA, Lee SW-M, Weesie RJ, Jackson MJ, Britton G. 1997. Oxidation of carotenoids by free radicals: relationship between structure and reactivity. Biochim. Biophys. Acta 1336:33-42
156. Wooten BR, Hammond BR. 2002. Macular pigment: influences on visual acuity and visibility. Prog. Retin. Eye Res. 21:225-40
157. Wooten BR, Hammond BR Jr., Land RI, Snodderly DM. 1999. A practical method for measuring macular pigment optical density. Invest. Ophthalmol. Vis. Sci. 40:2481-89
158. Wooten BR, Wald G. 1973. Color-vision mechanisms in the peripheral retinas of normal and dichromatic observers. J. Gen. Physiol. 61:125-45
159. Wustemeyer H, Jahn C, Nestler A, Barth T, Wolf S. 2002. A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch. Clin. Exp. Ophthalmol. 240:666-71
160. Yemelyanov AY, Katz NB, Bernstein PS. 2001. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp. Eye Res. 72:381-92
161. Yeum K-J, Booth S, Sadowski J, Lin C, Tang G, et al. 1996. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am. J. Clin. Nutr. 64:594-602
162. Yeum K-J, Taylor A, Tang G, Russell RM. 1995. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest. Ophthalmol. Vis. Sci. 36:2756-61
163. Yeum KJ, Shang FM, Schalch WM, Russell RM, Taylor A. 1999. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr. Eye Res. 19:502-5
164. Young AJ, Lowe GM. 2001. Antioxidant and prooxidant properties of carotenoids. Arch. Biochem. Biophys. 385:20-27
165. Zechmeister L. 1962. Cis-Trans Isomeric Carotenoids, Vitamins A, and Arylpolyenes. New York: Academic. 251 pp.